Autonomic Markers and Cardiovascular and Arrhythmic Events in Heart Failure Patients: Still a Place in Prognostication? Data from the GISSI-HF Trial
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Aims: To investigate the prognostic value of autonomic variables in patients with symptomatic chronic heart failure (HF) treated according to current recommendations. Methods and results: We analysed 24 h time-domain [standard deviation of all normal-to-normal RR intervals (SDNN)], frequency-domain [very low frequency and low frequency power (VFLP and LFP)], and non-linear [detrended fluctuation analysis (DFA)] heart rate variability, deceleration capacity (DC), and heart rate turbulence (HRT) in 388 sinus rhythm HF patients enrolled in the GISSI-HF Holter substudy [82% males, age 65 ±10 years, New York Heart Association (NYHA) functional class III–IV 20%, left ventricular ejection fraction (LVEF) 33 ±8%]. Cardiovascular (CV) mortality and combined sudden death + implantable cardioverter defibrillator (ICD) discharge were assessed as a function of continuous variables in the entire population and in patients with LVEF >30% in univariate and multivariable Cox proportional hazards models. After a median of 47 months, 57 patients died of CV causes and 47 experienced the arrhythmic endpoint. For CV mortality, VLFP, LFP, and turbulence slope (TS) improved predictive discrimination (c-index) and risk classification [integrated discrimination improvement (IDI)] when added to clinical variables [age ≥70 years, LVEF, non-sustained ventricular tachycardia (NSVT), serum creatinine], while for arrhythmic mortality although the c-index increased in all three autonomic markers, the results of the IDI were statistically significant only for TS when added to NSVT, serum creatinine, and ischaemic aetiology. In 194 patients with LVEF >30% (20 arrhythmic events), the hazard ratio of an impaired TS (<2.5 msper RR interval) was 3.81 (95% confidence interval 1.35–10.7,P = 0.012) after adjustment for serum creatinine. Conclusions: Autonomic indexes still have independent predictive value on long-term outcome in HF patients. HRT may help in identifying patients with LVEF >30% at increased arrhythmic risk. Trial registration NCT00336336
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, both the MUSIC and GISSI-HF trials, which enrolled ambulatory patients with mild-tomoderate heart failure, documented that abnormal TS predicts not only total mortality but also SCD and/or appropriate ICD discharge (Cygankiewicz et al., 2008;La Rovere et al., 2012).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as La Rovere et al., 2012
In the citing paper
“The GISSI Holter substudy in a contemporary population of heart failure patients showed that SDNN, VLF, LF, and detrended fluctuation analysis were independent risk predictors for cardiovascular death, while VLF and LF were associated with sudden death or appropriate ICD discharge (La Rovere et al., 2012).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as La Rovere et al., 2012
In the citing paper
“Multiple studies have consistently confirmed the prognostic value of HRV in predicting overall mortality and heart failure progression (La Rovere et al., 2003Rovere et al., , 2012)).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as La Rovere et al., 2012
In the citing paper
“Abnormal HRT seems to be particularly useful in identifying high-risk patients among those with LVEF .30%(Bauer et al., 2008;Cygankiewicz et al., 2009;La Rovere et al., 2012) and is frequently evaluated in risk scores that combine assessment of arrhythmogenic substrate (low LVEF), repolarization instability (e.g., TWA), and abnormal autonomic nervous system tone (HRV).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as La Rovere et al., 2012
Citations
Cites
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series
Peng, C.-K., Havlin, S., Stanley, H. E., & Goldberger, A. L. (1995) · Chaos: An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/1.166141 · Cited by 3,855
Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189375 · Cited by 1,450
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
La Rovere, M. T., Pinna, G. D., Maestri, R., Mortara, A., Capomolla, S., Febo, O., Ferrari, R., Franchini, M., Gnemmi, M., Opasich, C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047275.25795.17 · Cited by 917
Self-citationRenal Impairment and Outcomes in Heart Failure
Smith, G. L., Lichtman, J. H., Bracken, M. B., Shlipak, M. G., Phillips, C. O., DiCapua, P., & Krumholz, H. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.084 · Cited by 897
La Rovere, M. T., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A., Nohara, R., Bigger, J. T., Camm, A. J., & Schwartz, P. J. (2001) · Circulation · doi:10.1161/01.cir.103.16.2072 · Cited by 697
Self-citationHuikuri, H. V., Mäkikallio, T. H., Peng, C.-K., Goldberger, A. L., Hintze, U., & Møller, M. (2000) · Circulation · doi:10.1161/01.cir.101.1.47 · Cited by 669
Bauer, A., Kantelhardt, J. W., Barthel, P., Schneider, R., Mäkikallio, T., Ulm, K., Hnatkova, K., Schömig, A., Huikuri, H., Bunde, A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68735-7 · Cited by 647
Cited by
Sassi, R., Cerutti, S., Lombardi, F., Malik, M., Huikuri, H. V., Peng, C.-K., Schmidt, G., Yamamoto, Y., Reviewers:, D., Gorenek, B., et al. (2015) · Europace · doi:10.1093/europace/euv015 · Cited by 727
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
“Decreased HRV values have been consistently reported in post-MI infarction and heart failure patients (Bigger et al., 1992; Kleiger et al., 1987; La Rovere et al., 2003, 2012; Makikallio et al., 2005).”
BackgroundResultInfluentialOmega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295
Metadata
- Authors
- La Rovere, M. T., Pinna, G. D., Maestri, R., Barlera, S., Bernardinangeli, M., Veniani, M., Nicolosi, G. L., Marchioli, R., Tavazzi, L., & for the GISSI-HF Investigators
- Affiliations
- Divisione di Cardiologia, e Bioingegneria, Fondazione ‘Salvatore Maugeri’, IRCCS, Istituto Scientifico di Montescano , Montescano ,
- Fondazione Salvatore Maugeri (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- USL 4 , Terni ,
- Ospedale Civile Rho (Milano)
- Azienda Ospedaliera Santa Maria Degli Angeli (IT)
- Mario Negri Sud Foundation (IT)
- Maria Cecilia Hospital (IT)
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-01
- Volume
- 14
- Issue
- 12
- Pages
- 1410-1419
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W1996582946
- Cited by
- 82
- References
- 29
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 8 · 2012: 2
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- heart failure, autonomic dysfunction, heart rate variability, heart rate turbulence, sudden cardiac death, cardiovascular mortality, arrhythmia risk, left ventricular ejection fraction, GISSI-HF trial, prognostic factors, detrended fluctuation analysis, deceleration capacity, implantable cardioverter-defibrillator, non-sustained ventricular tachycardia
- MeSH terms
- Aged, Arrhythmias, Cardiac, Autonomic Nervous System, Double-Blind Method, Female, Heart Failure, Heart Rate, Humans, Male, Prognosis, Risk Factors, Fatty Acids, Omega-3, Electrocardiography, Ambulatory, Proportional Hazards Models, Defibrillators, Implantable, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autonomic Markers and Cardiovascular and Arrhythmic Events in Heart Failure Patients: Still a Place in Prognostication? Data from the GISSI-HF Trial. https://app.cochat.ai/papers/10.1093/eurjhf/hfs126
- The paper
- La Rovere, M. T., Pinna, G. D., Maestri, R., Barlera, S., Bernardinangeli, M., Veniani, M., Nicolosi, G. L., Marchioli, R., Tavazzi, L., & for the GISSI-HF Investigators. (2012). Autonomic Markers and Cardiovascular and Arrhythmic Events in Heart Failure Patients: Still a Place in Prognostication? Data from the GISSI-HF Trial. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs126
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.